๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Dublin
Clinical trial register · Ireland

Clinical Trials in Dublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 615 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
321
Recruiting now
open to new participants
180
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 321 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC 36 University College Dublin 21 Royal College of Surgeons, Ireland 18 AbbVie 16 Bristol-Myers Squibb 14
Site location
Dublin 483 Cork 170 Galway 124 Limerick 56 Waterford 51
All 37 locations
Target enrolment
to

Trials with a site in Dublin

483 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483 Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Dublin
2027-11-23
Not yet open
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408 Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
2,380
Tallaght, Drogheda, Dublin
2026-12-16
Not yet open
Tracheostomy Practice in Adult Intensive Care Units
NCT07769021 Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU)
Royal College of Surgeons, Ireland
Observational
2,500
Dublin, Galway
2026-11-02
Not yet open
Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
NCT06749327 Cardiometabolic Risk Factors
Queen's University, Belfast
Not applicable
330
Dublin
2026-10-01
Not yet open
OPTIMISE Lung SABR
NCT07777614 Non Small Cell Lung Cancer
Cancer Trials Ireland
Phase 2
208
Dublin
2026-10
Recruiting
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161 Myelofibrosis, Anemia
Takeda
Phase 3
324
Cork, Dublin, Galway
2026-09-02
Recruiting
Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
NCT07507500 Myocardial Infarction (MI)
Instituto de Investigaciรณn Sanitaria de la Fundaciรณn Jimรฉnez Dรญaz
Phase 4
8,100
Dublin
2026-09-02
Not yet open
The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.
NCT07559643 Bariatric Surgery, Anti-Xa Activity, VTE (Venous Thromboembolism), Obesity & Overweight
University College Dublin
Not applicable
180
Dublin
2026-08-01
Recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680 Solid Tumors
Bristol-Myers Squibb
Phase 2
260
Cork, Dublin
2026-07-27
Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
NCT07575269 Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation
Boston Scientific Corporation
Not applicable
571
Dublin
2026-07-07
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632 Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Cork, Dublin, Limerick, Tullamore, Waterford
2026-06-26
Recruiting
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ยฑ Obinutuzumab
NCT07024706 Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
AstraZeneca
Phase 2
80
Dublin
2026-06-04
Recruiting
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
NCT06494878 Venous Thromboembolism, Postpartum Period, Aspirin, Low Molecular Weight Heparin
University of Calgary
Phase 3
8,805
Dublin
2026-06-04
Not yet open
A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer
NCT07455422 Barrett Esophagus, Barrett Esophagus Adenocarcinoma, Adenocarcinoma - GEJ, Gastroenterology
University Hospital, Antwerp
Not applicable
266
Dublin
2026-06-01
Recruiting
Eating Behaviour Before, During, and After Obesity Medication
NCT07636395 Obesity Type 2 Diabetes Mellitus, Obesity & Overweight
University College Dublin
Observational
30
Dublin
2026-05-25
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT07422480 Myelodysplastic Syndrome, Anemia
Takeda
Phase 3
300
Cork, Dublin, Galway
2026-05-21
Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
NCT07287098 Breast Neoplasms
Eli Lilly and Company
Phase 2
600
Dublin, Galway
2026-05-13
Recruiting
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
NCT07555483 Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
40
Dublin
2026-05-05
Recruiting
The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care
NCT07609134 Asthma, Self-management, Asthma Control
Royal College of Surgeons, Ireland
Not applicable
40
Dublin
2026-05
Recruiting
NeoSHARK: Anatomical Versus Round Facemasks for Breathing Support in Preterm and Term Newborn Infants
NCT07524517 Neonatal Intensive Care
University College Dublin
Not applicable
50
Dublin
2026-05
Recruiting
INSPIRE: INnovative SABR for Prostate Cancer All IREland
NCT07552168 Prostate Adenocarcinoma
Cancer Trials Ireland
Phase 2
136
Dublin, Cork, Waterford
2026-04-23
Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
NCT07546500 Ovarian Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Cork, Dublin
2026-04-17
Recruiting
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
NCT07523620 Atrial Fibrillation (AF), Paroxysmal AF, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
240
Dublin
2026-03-31
Recruiting
InRAD Observational Study
NCT07213700 Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Non-Alzheimer Degenerative Dementia
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Observational
50,000
Dublin
2026-03-30
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351 Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb
Phase 1/2
474
Dublin
2026-03-26
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497 Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 3
850
Cork, Dublin
2026-03-16
Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT07218341 Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Eli Lilly and Company
Phase 4
150
Dublin
2026-03-09
Not yet open
The Effectiveness of the Twin Block and Carriere Motion Appliances in Post-pubertal Patients and an Evaluation of the Impact of Class II Malocclusion and Its Correction on Oral Health-related Quality of Life
NCT07292636 CLASS II DIVISION 1 MALOCCLUSION, Class II Malocclusion, Growth, Overjet
Aslam Alkadhimi
Not applicable
88
Dublin
2026-03
Not yet open
Exploring the Feasibility of Using Virtual Reality as an Educational Tool in Chronic Pain Rehabilitation
NCT07434804 Pain, Chronic Pain, Chronic Pain (Back / Neck), Adults
University College Dublin
Not applicable
50
Dublin
2026-02-20
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07335497 Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc.
Phase 1/2
290
Dublin
2026-02-17
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558 Ovarian Neoplasms, Ovarian Cancer
Merck Sharp & Dohme LLC
Phase 3
900
Cork, Dublin
2026-02-16
Recruiting
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
NCT07223203 Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN
Alnylam Pharmaceuticals
Phase 3
125
Dublin
2026-02-03
Recruiting
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
NCT07322003 Amyotrophic Lateral Sclerosis
Prilenia
Phase 3
500
Dublin
2026-02-01
Recruiting
Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
NCT07592234 Serious Adverse Events, Patient Safety, Pharmacovigilance, Oncology
St Vincent's University Hospital, Ireland
Observational
100
Dublin
2026-02-01
Not yet open
Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
NCT07310914 Multiple Sclerosis
Danish Multiple Sclerosis Hospitals
Phase 2
94
Dublin
2026-02-01
Not yet open
Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome
NCT07386483 Psychosis
University College Dublin
Not applicable
40
Dublin
2026-02-01
Recruiting
Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus
NCT07393880 Tinnitus, Subjective, Tinnitus, Chronic Tinnitus
University of Dublin, Trinity College
Not applicable
100
Dublin
2026-01-30
Recruiting
Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis
NCT07489521 Osteo Arthritis Knee, Osteoarthritis, Intraarticular Injection
Cappagh National Orthopaedic Hospital
Phase 4
200
Dublin
2026-01-29
Recruiting
Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT07402915 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal
AstraZeneca
Phase 1
24
Dublin
2026-01-26
Recruiting
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
NCT07332091 Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring
Phase 2
84
Cork, Dublin
2026-01-22
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703 Cervical Cancer
Merck Sharp & Dohme LLC
Phase 3
1,023
Cork, Dublin
2026-01-19
Active, closed
Probiotic in Fruit Snack
NCT07679490 Colonization, Asymptomatic, Probiotic Intervention, Gut Microbiota Diversity and Composition, Gut-brain Axis
University College Dublin
Not applicable
25
Dublin
2026-01-18
Recruiting
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
NCT07561957 Chronic Kidney Disease, Proteinuria, Blood Pressure Control, Congenital Anomalies of the Kidneys and Urinary Tract
St. James's Hospital, Ireland
Not applicable
80
Dublin
2026-01-14
Recruiting
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
NCT06931717 Non-Small Cell Lung Cancer
ETOP IBCSG Partners Foundation
Phase 3
390
Cork, Dublin
2026-01-12
Recruiting
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172 Breast Cancer
University Hospital, Basel, Switzerland
Not applicable
1,060
Cork, Dublin, Galway
2026-01-01
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809 Epithelial Ovarian Cancer
AstraZeneca
Phase 3
1,100
Cork, Dublin, Waterford
2025-12-29
Recruiting
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06932562 Multiple Myeloma
European Myeloma Network B.V.
Phase 3
1,000
Cork, Dublin, Limerick
2025-12-23
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336 Breast Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
800
Cork, Dublin, Galway
2025-12-22
Recruiting
The PHARO Trial: The Incidence of Para-conduit Hernia With Closure of Hiatus Versus the Standard Approach in Robotic Oesophagectomy - A Randomised Controlled Pilot Trial
NCT07426835 Oesphageal Cancer, Para-conduit Hernia
Royal College of Surgeons, Ireland
Not applicable
40
Dublin
2025-12-19
Recruiting
OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients
NCT07426848 Primary Brain Tumour, Glioblastoma, Brain Neoplasms
Royal College of Surgeons, Ireland
Not applicable
96
Dublin
2025-12-18
Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
NCT07266428 Advanced Solid Tumors
Ottimo Pharma Limited
Phase 1/2
170
Dublin
2025-12-17
Recruiting
The Impact of Concurrent Training on Women Experiencing Symptoms of Menopause
NCT07417228 Menopause Symptoms
University College Dublin
Not applicable
90
Dublin
2025-12-12
Recruiting
Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer
NCT07572370 Breast Cancer
Royal College of Surgeons, Ireland
Observational
560
Dublin
2025-12-11
Recruiting
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
NCT07181590 Paroxysmal AF, Atrial Arrhythmia, Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Dublin
2025-12-11
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397 Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
Cybin IRL Limited
Phase 3
330
Dublin, Galway
2025-12-10
Recruiting
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
NCT07401550 Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery Disease (CAD)
University College Dublin
Observational
100
Dublin
2025-12-09
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779 Ovarian Cancer
Incyte Corporation
Phase 3
466
Dublin, Galway, Waterford
2025-12-09
Recruiting
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07244341 Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo
Phase 1
60
Dublin
2025-12-03
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
NCT07227402 Renal Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 3
904
Cork, Dublin
2025-11-26
Recruiting
Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)
NCT07425002 Breast Cancer
Cancer Trials Ireland
Not applicable
1,600
Dublin, Cork, Galway
2025-11-11
Recruiting
Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor
NCT07512505 Cancer, Malignancies Multiple, Terminal Care, Hospice
Our Lady's Hospice and Care Services
Observational
120
Dublin
2025-11-06
Not yet open
An Exploratory Feasibility Study
NCT07009964 Well-Being, Lifestyle, Healthy, Young Adult, Behavior and Behavior Mechanisms
University College Dublin
Not applicable
12
Dublin
2025-11-01
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215 Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Hoffmann-La Roche
Phase 3
600
Dublin
2025-10-24
Active, closed
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121 Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb
Phase 2/3
470
Dublin
2025-10-23
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804 Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
1,630
Cork, Dublin
2025-10-22
Recruiting
A Study of ZW251 in Participants With Advanced Solid Tumors
NCT07164313 Hepatocellular Carcinoma, Squamous Cell Non-Small Cell Lung Cancer, Germ Cell Tumor
Zymeworks BC Inc.
Phase 1
100
Dublin
2025-10-21
Recruiting
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
NCT07115004 Von Willebrand Disease (VWD)
Vega Therapeutics, Inc
Phase 3
60
Dublin
2025-10-15
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
NCT07807111 Retinitis Pigmentosa (RP), Rod Cone Dystrophy
SparingVision
Phase 1/2
27
Dublin
2025-10-08
Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
NCT07142304 Chemotherapy Induced Peripheral Neuropathy (CIPN)
Luminate Medical, Inc.
Not applicable
142
Dublin
2025-10-03
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
NCT07207811 Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S
Phase 3
1,280
Ballinasloe, Dublin, Letterkenny
2025-10-02
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714 Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Dublin
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044 Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Dublin
2025-10-01
Recruiting
Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
NCT07196020 Venous Thromboembolism, Cancer
University of Dublin, Trinity College
Observational
380
Cork, Dublin
2025-10-01
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
NCT07204275 Primary Membranous Nephropathy
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Cork, Dublin, Galway
2025-09-30
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762 Urothelial Cancer
Bristol-Myers Squibb
Phase 2/3
470
Cork, Dublin
2025-09-30
Recruiting
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
NCT06865417 Ulcerative Colitis
Alfasigma S.p.A.
Phase 3
80
Dublin
2025-09-29
Recruiting
Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients
NCT07182773 Cancer
University of Dublin, Trinity College
Not applicable
80
Dublin
2025-09-24
Recruiting
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NCT07115953 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
130
Dublin
2025-09-22
Recruiting
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
NCT07023835 Amyotrophic Lateral Sclerosis (ALS)
Zydus Therapeutics Inc.
Phase 2
240
Dublin
2025-09-17
Recruiting
Obstructive Sleep Apnoea and Difficult Asthma (OSADA)
NCT07160868 Asthma (Diagnosis), OSA - Obstructive Sleep Apnea, CPAP Treatment
St. James's Hospital, Ireland
Not applicable
80
Dublin
2025-09-01
Active, closed
Mindful-Med: the Evaluation of the Mindfulness-based Stress-coping and Burnout Prevention Programme for Medical Interns.
NCT07171697 Stress (Psychology), Burnout, Mindfulness
Royal College of Surgeons, Ireland
Not applicable
24
Dublin
2025-09-01
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524 Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Cork, Dublin, Galway
2025-08-21
Recruiting
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT06523374 Barrett's Esophagus, Esophageal Adenocarcinoma
University Hospital, Antwerp
Not applicable
50
Dublin
2025-08-13
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
NCT07099898 Neoplasms, Lung
GlaxoSmithKline
Phase 3
420
Dublin
2025-08-11
Recruiting
Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation Compared to Single Device Treatments in Patients With Diabetes Mellitus
NCT07303439 Diabetes Mellitus, Coronary Arterial Disease (CAD), de Novo Coronary Lesions, De Novo Stenosis
Royal College of Surgeons, Ireland
Not applicable
120
Dublin
2025-08-06
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016 Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Cork, Dublin, Galway
2025-08-05
Recruiting
Comparison of 'Sip Til Send' Regimens Prior to Elective Caesarean Delivery Using Bedside Gastric Ultrasound
NCT07407530 Gastric Emptying, Caesarean Delivery, Pregnancy
The Rotunda Hospital
Not applicable
190
Dublin
2025-08-01
Not yet open
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery
NCT07100691 Pulmonary Aspiration During Anaesthetic Induction, Gastric Emptying Time, Preoperative Risk Assessment, Obesity (Disorder)
Mater Misericordiae University Hospital
Phase 4
80
Dublin
2025-08
Recruiting
Harmony TPV EMEA PMS
NCT06906926 Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular
Not applicable
80
Dublin
2025-07-30
Active, closed
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT06808217 Atrial Fibrillation, Pulsed Field Ablation, FARAPULSE
Boston Scientific Corporation
Observational
550
Dublin
2025-07-30
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473 Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Boehringer Ingelheim
Phase 3
11,800
Ballinasloe, Dublin, Galway
2025-07-22
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
NCT06863272 Castration-Resistant Prostatic Cancer, Metastasis
Merck Sharp & Dohme LLC
Phase 1/2
360
Dublin
2025-07-03
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT07052903 Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
Phase 3
1,750
Dublin
2025-07-02
Active, closed
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
NCT06981078 Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.
Phase 2
666
Dublin, Tallaght, Drogheda
2025-07-02
Active, closed
Safety Study of Viaskinยฎ Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
NCT07003919 Allergy, Peanut Allergy
DBV Technologies
Phase 3
480
Cork, Dublin
2025-06-24
Active, closed
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
NCT06880744 Ulcerative Colitis
AbbVie
Phase 3
573
Ballinasloe, Drogheda, Mullingar, Dublin
2025-06-17
Recruiting
A Phase 2 Study of Mutant-selective PI3Kฮฑ Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
NCT06789913 PIK3CA-Related Overgrowth Spectrum (PROS), Lymphatic Malformations, Vascular Malformations, PIK3CA Mutation
Relay Therapeutics, Inc.
Phase 2
277
Dublin
2025-06-13
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872 Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
630
Dublin, Galway, Limerick
2025-06-11
Recruiting
The AIRTIVITYโ„ข Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 Bronchiectasis
Boehringer Ingelheim
Phase 3
1,755
Cork, Dublin
2025-06-09
Recruiting
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia
NCT06953583 Friedreich Ataxia
Biogen
Phase 3
255
Dublin
2025-06-09
Rows per page Showing 1–100 of 483
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/dublin

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 615 studies in total at the last sync on 23 Sep 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 483 of those studies with a site in Dublin.

How many clinical trials are recruiting in Dublin?

246 of the 483 studies on this page are recruiting new participants as of the 23 Sep 2026, 03:15 UTC sync. A further 19 have not yet opened recruitment, 203 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dublin), 483 studies
PhaseStudiesRecruitingShare
Phase 32259046.6%
Observational805516.6%
Not applicable734015.1%
Phase 2502410.4%
Phase 1/221194.3%
Phase 2/31462.9%
Phase 11072.1%
Phase 41052.1%

Most active sponsors

Lead sponsors with the most studies (Dublin)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC3619
University College Dublin2111
Royal College of Surgeons, Ireland1813
AbbVie162
Bristol-Myers Squibb146
Cancer Trials Ireland137
AstraZeneca106
Eli Lilly and Company97
Takeda88
University of Dublin, Trinity College85
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.